Since the epidermal growth factor receptor (EGFR) is overexpressed in a high range of CRC tumors [37, 38], it represents an auspicious target for tumor-specific NIS gene delivery via actively targeted nanoparticle transfer. The gene discussed is EGFR; the disease is colorectal carcinoma.